(Press-News.org) Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
The November issue of the CHEST journal contains 48 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary resources, including visual abstracts, podcasts and more to summarize and share expert commentary on select research.
“The 2023 Canadian Thoracic Society guideline on pharmacotherapy in patients with stable COPD is published in this month’s issue of [the journal] CHEST,” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “This guideline provides updated recommendations based on newly published literature since the 2019 guideline, Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Read the latest guideline.”
Additional highlights from the latest issue of the journal CHEST include:
In a post hoc comparison using data from 2,436 patients, “Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma” showed that home spirometry was less consistent than and lacked agreement with clinic spirometry. View the visual abstract for this research.
Original research, “CT Imaging With Machine Learning for Predicting Progression to COPD in Individuals at Risk,” suggests that identifying individuals at risk of COPD progression may allow for initiation of treatment to potentially slow the progression of the disease.
Diffuse Lung Disease
A prospective observational cohort study, “Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease,” finds that prolonged nocturnal hypoxemia is associated with worsening disease-related quality of life and increased mortality in patients with fibrotic interstitial lung disease. View the visual abstract for this research.
“Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath” shows that electronic nose assessment may detect early stages of lung cancer in patients with COPD.
To view the entire November issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on social media for the latest journal news.
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 22,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.
Highlights from the journal CHEST®, November 2023
ELSE PRESS RELEASES FROM THIS DATE:
Three-pronged approach discerns qualities of quantum spin liquids
In 1973, physicist Phil Anderson hypothesized that the quantum spin liquid, or QSL, state existed on some triangular lattices, but he lacked the tools to delve deeper. Fifty years later, a team led by researchers associated with the Quantum Science Center headquartered at the Department of Energy’s Oak Ridge National Laboratory has confirmed the presence of QSL behavior in a new material with this structure, KYbSe2. QSLs — an unusual state of matter controlled by interactions among entangled, or intrinsically linked, magnetic atoms called spins — excel at stabilizing quantum mechanical activity in KYbSe2 and other delafossites. These materials are prized for ...
Cancer therapy shows promise against tuberculosis
A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists at Texas Biomedical Research Institute (Texas Biomed) found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant. The findings, reported in the journal Biomedicine & Pharmacotherapy, were made in novel cellular models featuring TB-infected human cells that can help accelerate screening of potential TB drugs and therapies like this one. The therapy evaluated in this study combines two ...
Theoretical computer scientists awarded the John von Neumann Theory Prize
Computer Science Professors Christos Papadimitriou and Mihalis Yannakakis received the John von Neumann Theory Prize for their research in computational complexity theory that explores the boundaries of efficiently solving decision and optimization problems crucial to operations research and management sciences. The recipients were presented with the prize at the 2023 INFORMS Annual Meeting in October in Phoenix, AZ. The Institute for Operations Research and the Management Sciences (INFORMS) first awarded the prize in 1975 to honor a body of work that has proven its lasting value in operations research and management sciences. ...
Heat tolerant coral may trade fast growth for resilience
Algae living within the soft tissue of coral supply much of the energy needed by their hosts, and some symbiotic algae help coral withstand warmer water better than others. In a recently published study led by the University of Hawai‘i at Mānoa, researchers found that there was a tradeoff for corals dominated by the thermally sensitive algae—they have higher growth, but only in cooler water. “As the ocean continues to warm, understanding how symbionts and environmental factors affect coral growth and health will help predict reef futures and inform conservation interventions where coral stocks are selected ...
Genomic tug of war could boost cancer therapy
Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine’s effects or become resistant over time. Wilmot Cancer Institute researchers have uncovered a “genomic tug of war” in animal studies that could influence how well certain patients—or certain cancers—respond to decitabine. In a study published in the journal Development, ...
New research questions the nature and meaning of "psychic-channeling" experiences
The question of disembodied consciousness or the afterlife has received much scientific scrutiny over the last several years. One line of research involves so-called "channelers" or mediums who claim to receive and communicate information that they believe comes from some other being or dimension of reality that differs from everyday reality. Now, an international team of scientists has critically examined these claims. New research published in the Journal of Scientific Exploration asked 15 pre-vetted channelers to access the same "nonphysical being or spirit" source and answer a structured set of 10 questions from the scientific team. The statistical ...
Drug manufacturers use FDA, patent strategies to keep insulin prices high
Over the last four decades, insulin manufacturers have extended their periods of market exclusivity on brand-name insulin products by employing several strategies, including filing additional patents on their products after FDA approval and obtaining many patents on delivery devices for their insulin products. That is the conclusion of a new analysis of FDA and patent records carried out by William Feldman of Brigham and Women’s Hospital, USA, and colleagues, and published November 16th in the open access journal PLOS Medicine. Insulin is the primary, life-saving treatment for type 1 and some type 2 diabetes but remains costly in the US even ...
Growing income inequities in the utilization of healthcare resources, Swedish study finds
Swedish people with the lowest incomes utilize primary and outpatient care on par with those with the highest incomes despite having significantly higher mortality rates, according to a new study published November 16th in the open access journal PLOS Medicine by Pär Flodin of Karolinska Institutet, Sweden, and colleagues. Socioeconomic differences in healthcare utilization have persisted in modern welfare states even with universal healthcare. In recent decades, Sweden has witnessed a rise in income inequalities, accompanied by shifts in the sociodemographic composition of the population ...
Love thy neighbor: Cooperation extends beyond one’s own group in wild bonobos
A new study published this week in Science challenges the notion that only humans are capable of forming strong and strategic cooperative relationships and sharing resources across non-family groups. Researchers from Harvard University and the German Primate Center examined the pro-social behavior of bonobos (Pan paniscus), one of humanity’s closest living relatives, finding that their cooperation extends beyond one’s own group to societal cooperation with different groups. Studying humans' two closest living relatives, chimpanzees and bonobos, can help reconstruct ancestral human traits like cooperation and conflict. Despite living in similar ...
New molecular glue degraders could help target troublesome proteins
Cells contain molecular machinery that targets and disposes of unwanted proteins to maintain homeostasis. Scientists think that with the help of “matchmaker” molecules called molecular glue degraders, this machinery could be hijacked to control proteins involved in diseases like cancer. But only a few of these glue degraders have been discovered so far—and mostly by chance. Zuzanna Kozicka, as a Ph.D. student at Friedrich Miescher Institute in Basel, Switzerland, embarked on a deliberate search for these glues with her team and identified a novel class of molecular glue degraders with more than 40 chemically diverse members. Kozicka, who is now a postdoctoral ...